Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review

Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review

BackgroundThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is currently the dominant variant globally. This third interim analysis of a living systematic review summarizes evidence on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine (vaccine effect...

Full description

Bibliographic Details
Main Authors: Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, Madeleine Batke, Léa-Sophie Dreveton, Brogan Geurts, Judith Koch, Stefan Köppe, Marina Treskova, Sabine Vygen-Bonnet, Maria Waize, Ole Wichmann, Thomas Harder
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
systematic review
vaccine effectiveness
vaccination
COVID-19
Omicron variant
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.940562/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.940562/full

Similar Items